Description
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) is participating in the American Heart Association Scientific Sessions 2018. NHLBI-supported research will be presented at more than 80 sessions. See the schedule below for a snapshot of the NHLBI’s sessions at #AHA18.
NOTE: Times subject to change. Please consult the official AHA schedule.
NHLBI Research & NHLBI-Funded Research Sessions at AHA 2018
Saturday, November 10, 2018
Late Breaking Science
9:00 a.m. Contemporary Disease Burden in Ambulatory Advanced Heart Failure: Two-year Outcomes from the Registry Evaluation of Vital Information for VADS in Ambulatory Life (REVIVAL)
Session LBP.02
Location: N228
Presenter: Keith Aaronson, M.D., University of Michigan Health System
2:00 p.m. The VITamin D and OmegA-3 TriaL (VITAL): Principal Results for Vitamin D and Omega-3 Fatty Acid Supplementation in the Primary Prevention of Cardiovascular Disease and Cancer
Session LBS.01: 19539
Location: Main Event I
Presenter: JoAnn Manson, M.D., M.P.H., Dr.P.H., Brigham and Women’s Hospital
4:00 p.m. The Cardiovascular Inflammation Reduction Trial (CIRT): Low Dose Methotrexate for the Prevention of Atherosclerotic Events
Session LBS.02: 17778
Location: Main Event I
Presenter: Paul Ridker, M.D., Brigham and Women’s Hospital
NHLBI Research
11:30 a.m. Change in Small Dense Low-Density Lipoprotein Particle Number Relates to Change in Coronary Plaque Burden Independent of Traditional Cardiovascular Risk Factors in Psoriasis
Session CM.APS.03: Sa1024
Location: Zone 1, Science and Technology Hall
Presenter: Nehal N. Mehta, M.D.
2:15 p.m. Immunomodulatory Therapy Favorably Modifies Coronary Plaque Morphology in Psoriasis
Session IM.APS.21: Sa4228
Location: Zone 4, Science and Technology Hall
Presenter: Youssef A. Elnabawi
2:15 p.m. Thoracic Aortic Wall Thickness and Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA)
Session IM.APS.22: Sa4229
Location: Zone 4, Science and Technology Hall
Presenter: Nehal N. Mehta, M.D.
2:15 p.m. Increased Resting Amygdala Activity Relates to Increased Prevalence of High Risk Coronary Plaque in Psoriasis
Session IM.APS.24: Sa4254
Location: Zone 4, Science and Technology Hall
Presenter: Nehal N. Mehta, M.D.
2:45 p.m. Population-Based Burden of Sudden Death in the Young in a United States Cohort
Session CH.AOS.01: 179
Location: S101a
Presenter: Jonathan R. Kaltman, M.D.
NHLBI Cardiovascular Seminars
7:15 a.m. Starting and Maintaining a Research Career in Clinical or Population Science
Session VA.CVS.1360
Location: S106a
Panelist: Jane D. Scott, Sc.D., M.S.N.
10:45 a.m. Using Data to Drive Improvements in Congenital and Acquired Heart Disease
Session CH.CVS.1364
Location: S101b
Moderator: Gail Pearson, M.D., Sc.D.
2:00 p.m. The Millennials Are Coming! Challenges and Opportunities for Cardiovascular Disease Prevention
Session EP.CVS.1406
Location: N229
Moderator: Nicole Redmond, M.D., Ph.D., M.P.H.
2:00 p.m. Rx for Behavior Change: Engaging Patients to Meet Guidelines
Session LF.CVS.1455
Location: N230b
Panelist: Catherine Stoney, Ph.D.
5:30 p.m. Global Roundtable: Are the Millennials (ages 15-35 years) Cardiovascular Disease Time Bombs?: AHA, Italian Association of Hospital Cardiologists, Chilean Society of Cardiology & The Danish Society of Cardiology
Session PR.JS.02
Location: N226
Moderator: Nicole Redmond, M.D., Ph.D., M.P.H.
5:30 p.m. Zip Codes are More Important than Genetic Codes: Social and Environmental Determinants of CVD Risk
Session QU.CVS.1383
Location: N139
Panelist: Tiffany M. Powell-Wiley, M.D., M.P.H.
NHLBI-Funded Research
11:30 a.m. Coronary Flow Capacity in Women With Suspected Ischemia With No Obstructive Coronary Artery Disease (INOCA): Findings from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
Session AC.APS.05: Sa2054
Location: Zone 2, Science and Technology Hall
Presenter: Chrisandra L. Shufelt, M.D., Cedars-Sinai Medical Center
11:30 a.m. Adipose Tissue Area and Progression of Coronary Plaque Among HIV-Infected- and Uninfected Men: Multicenter Aids Cohort Study (MACS)
Session CM.APS.03: Sa1026
Location: Zone 1, Science and Technology Hall
Presenter: Kazuhiro Osawa, M.D., Ph.D., LA Biomed, Harbor-UCLA Medical Center
11:30 a.m. Amino Acids Levels Are Not Associated With Incident Coronary Heart Disease in African Americans: A Metabolomic Investigation of the Jackson Heart Study
Session CM.APS.03: Sa1027
Location: Zone 1, Science and Technology Hall
Presenter: Daniel E. Cruz, M.D., Beth Israel Deaconess Medical Center
11:30 a.m. Novel Metabolite Associations With Coronary Artery Calcium Scores in African Americans: A Metabolomic Investigation of the Jackson Heart Study
Session CM.APS.03: Sa1030
Location: Zone 1, Science and Technology Hall
Presenter: Daniel E. Cruz, M.D., Beth Israel Deaconess Medical Center
11:30 a.m. Cumulative Psychosocial Stress and Incident Type II Diabetes in Older Women Participating in the Women’s Health Study
Session EP.APS.03: Sa1103
Location: Zone 1, Science and Technology Hall
Presenter: Jonathan Z. Butler, Ph.D., University of California San Francisco
11:30 a.m. Association of Nonsteroidal Anti-Inflammatory Drug Use With Incident Heart Failure Within the Multi-Ethnic Study of Atherosclerosis
Session EP.APS.04: Sa1113
Location: Zone 1, Science and Technology Hall
Presenter: William Mostertz, M.D., Wake Forest Baptist Medical Center
11:30 a.m. Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Multi Ethnic Cohort: MESA
Session EP.APS.05: Sa1126
Location: Zone 1, Science and Technology Hall
Presenter: Charles A. German, Wake Forest Baptist Medical Center
11:30 a.m. Shared Genetic and Environmental Architecture of Echocardiographic Traits: Bivariate Heritability and Environmental Correlations in the Framingham Study
Session EP.APS.06: Sa1130
Location: Zone 1, Science and Technology Hall
Presenter: Cecilia Castro-Diehl, M.P.H., Boston University School of Medicine
11:30 a.m. Prognostic Importance of Echocardiographic Measures of Cardiac Remodeling: A Comparative Analysis in a Community-Based Sample
Session EP.APS.06: Sa1131
Location: Zone 1, Science and Technology Hall
Presenter: Beatrice von Jeinsen, Kerckhoff Heart and Thorax Center
11:30 a.m. Joint Influences of Obesity, Diabetes, and Hypertension on the Indices of Ventricular and Vascular Remodeling: Findings in the Community-Based Framingham Study Sample
Session EP.APS.06: Sa1132
Location: Zone 1, Science and Technology Hall
Presenter: Beatrice von Jeinsen, Kerckhoff Heart and Thorax Center
11:30 a.m. Subclinical Atherosclerosis is Associated With Echocardiographic Indices of Cardiac Remodeling: The Framingham Study
Session EP.APS.06: Sa1133
Location: Zone 1, Science and Technology Hall
Presenter: Cecilia Castro-Diehl, M.P.H., Boston University School of Medicine
11:30 a.m. Association of Lung Diffusion Capacity with Cardiac Remodeling and Risk of Heart Failure in the Community
Session EP.APS.06: Sa1137
Location: Zone 1, Science and Technology Hall
Presenter: Patrick Field, M.D., Boston University School of Medicine
11:30 a.m. Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial
Session HF.APS.02: Sa2116
Location: Zone 2, Science and Technology Hall
Presenter: Stephen J. Greene, M.D., Duke University School of Medicine
11:30 a.m. Short-Term Changes in Indices of Disease Severity Impact Prognosis in Advanced Ambulatory Heart Failure
Session HF.APS.02: Sa2117
Location: Zone 2, Science and Technology Hall
Presenter: Michelle Kittleson, M.D., California Heart Center
11:30 a.m. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure: A Pooled, Patient-Level Analysis of the Heart Failure Network
Session HF.APS.02: Sa2118
Location: Zone 2, Science and Technology Hall
Presenter: Ravi B. Patel, M.D., Northwestern University Feinberg School of Medicine
11:30 a.m. Calcium Scoring Improves Pretest Probability Estimation of Obstructive Coronary Artery Disease in a Real World Population
Session IM.APS.03: Sa2325
Location: Zone 2, Science and Technology Hall
Presenter: Eileen Hu-Wang, Northwestern University Feinberg School of Medicine
11:30 a.m. Late Gadolinium Enhancement Scar Volume and Extra Cellular Volume Value Are Inversely Associated With Left Ventricular Ejection Fraction in Women With and Without Human Immunodeficiency Virus Infection
Session IM.APS.03: Sa2334
Location: Zone 2, Science and Technology Hall
Presenter: Yoko Kato, Johns Hopkins University
11:30 a.m. Relationship Between Sleep Debt and Obesity in Older Women: Findings From the Women’s Health Study
Session WS.APS.02: Sa2486
Location: Zone 2, Science and Technology Hall
Presenter: Stephanie T. Child, University of California San Francisco
2:00 p.m. Is Low Flow State With Normal Left Ventricular Ejection Fraction a Clinical Disorder? Cardiac Magnetic Resonance Imaging Investigation in the Multi-Ethnic Study of Atherosclerosis (MESA)
Session HF.RFO2: 407
Location: Zone 2, Science and Technology Hall
Presenter: Min Pu, M.D., Ph.D., Wake Forest Baptist Medical Center
2:00 p.m. Phenotype, but Not Genotype, Determines Survival in Pediatric Dilated Cardiomyopathy: A Study From the NHLBI-Funded Pediatric Cardiomyopathy Registry
Session CH.AOS.01: 176
Location: S101a
Presenter: Paul F. Kantor, Stollery Children’s Hospital
2:15 p.m. Challenges Encountered in the Pediatric Heart Network Echocardiogram Z-Score Study
Session CH.APS.10: Sa3099
Location: Zone 3, Science and Technology Hall
Presenter: Dongngan Truong, M.D., University of Utah
2:15 p.m. Pediatric Heart Network Echocardiographic Z Scores: Comparison to Other Published Models
Session CH.APS.10: Sa3103
Location: Zone 3, Science and Technology Hall
Presenter: Leo Lopez, M.D., Nicklaus Children’s Hospital
2:15 p.m. Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population: Risk Model Development and Validation
Session CH.APS.19: Sa3192
Location: Zone 3, Science and Technology Hall
Presenter: Mary Beth Son, M.D., Boston Children’s Hospital
2:15 p.m. C2 and Association With New Onset of Type 2 Diabetes Mellitus: The MESA Study
Session CM.APS.06: Sa1056
Location: Zone 1, Science and Technology Hall
Presenter: Daniel A. Duprez, M.D., Ph.D., University of Minnesota
2:15 p.m. Circulating Growth Factors and Cardiac Remodeling in The Framingham Heart Study
Session EP.APS.09: Sa1167
Location: Zone 1, Science and Technology Hall
Presenter: Cecilia Castro-Diehl, M.P.H., Boston University School of Medicine
2:15 p.m. Patterns of Oxygen Recovery Kinetics Following Maximal Exercise in the Framingham Heart Study
Session EP.APS.13: Sa1211
Location: Zone 1, Science and Technology Hall
Presenter: Jasmine B. Blodgett, Massachusetts General Hospital
2:15 p.m. Plaque Progression By Cardiovascular Disease Risk Scores in HIV Infected Compared to HIV Uninfected Men: Results From The MACS (Multicenter AIDS Cohort Study)
Session IM.APS.21: Sa4226
Location: Zone 4, Science and Technology Hall
Presenter: Kashif Shaikh, M.D., LA Biomed, Harbor-UCLA Medical Center
2:20 p.m. Lower Circulating Levels of Cyclic Guanosine Monophosphate Are Associated With Greater Concentric Left Ventricular Remodeling in the Multi-Ethnic Study of Atherosclerosis
Session HF.RFO2: 409
Location: Zone 2, Science and Technology Hall
Presenter: Vinita Subramanya, M.P.H., Johns Hopkins University School of Medicine
2:25 p.m. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality
Session EP.APS.12: Sa1201
Location: Zone 1, Science and Technology Hall
Presenter: Meredith S. Duncan, Vanderbilt University Medical Center
3:00 p.m. Regional Adiposity Depots & Risk of Incident Heart Failure Among African-Americans: Findings From the Jackson Heart Study
Session EP.RFO2: 407
Location: Zone 1, Science and Technology Hall
Presenter: Nitin Kondamudi, M.D., University of Texas Southwestern Medical Center
3:00 p.m. Impaired Left Ventricular Strain Despite Preserved Ejection Fraction and Risk of Incident Heart Failure With Ejection Fraction Above or Below 50% in Older Adults: The Community-Based Atherosclerosis Risk in Communities (ARIC) Study
Session HF.RFO2: 413
Location: Zone 2, Science and Technology Hall
Presenter: Anne Marie Reimer Jensen, Brigham and Women’s Hospital
4:45 p.m. Longitudinal Change in Exercise Capacity and Predictors of Performance After Fontan: Results From the Pediatric Heart Network Fontan 3 Study
Session CH.AOS.02: 183
Location: S101a
Presenter: David J. Goldberg, M.D., The Children’s Hospital of Philadelphia
Sunday, November 11, 2018
Late Breaking Science
6:30 p.m. Intramyocardial Injection of Mesenchymal Precursor Cells in Left Ventricular Assist Device Recipients: Impact on Myocardial Recovery and Morbidity
Session LBS.06: 19498
Location: Main Event II (s100)
Presenter: Francis D. Pagani, M.D., Ph.D., University of Michigan Medical School
Research Achievement Award
1:00 p.m.
PS.01. Presidential Session
Location: Main Event I
Awardee: Gary Gibbons, M.D., NHLBI Director
NHLBI Research
10:30 a.m. Re-Use of Clinical Trial Data From the NHLBI Data Repository (BioLINCC) for Patient-Level Meta-Analyses of Cardiovascular Outcomes: Challenges and Opportunities
Session EP.APS.20: Su1081
Location: Zone 1, Science and Technology Hall
Presenter: Ahmed A. Hasan, M.D., Ph.D.
11:15 a.m. Predictors of Death and Major Adverse Cardiovascular Events in the ACCORD Trial Identified by Random Survival Forest Based Machine-Learning
Session CM.AOS.01: 165
Location: N231
Presenter: Ahmed A. Hasan, M.D., Ph.D.
5:30 p.m. Melvin L. Marcus Young Investigator Award Competition
Session CA.AOS.02
Location: S402a
Moderator: Elizabeth Murphy, Ph.D.
NHLBI Cardiovascular Seminars
9:00 a.m. Epigenetic Mechanisms of Hypertension
Session HY.CVS.1323
Location: S104b
Panelist: Young S. Oh, Ph.D.
2:00 p.m. Developing Competency-Based Medical Nutrition Education and Training to Advance ASCVD Prevention by Physicians--Leveraging 21st Century Curricula Reforms, Population Health Goals, and NHLBI Roles/Partnerships
Session LF.CVS.2235
Location: N226
Panelist: Charlotte A. Pratt, Ph.D., RD
3:45 p.m. Vascular Modeling and Integrated Systems Biology Approaches
Session AT.CVS.2027
Location: S401abc
Panelist: Zorina S. Galis, Ph.D.
3:45 p.m. Effective Clinical Strategies to Reduce Obesity and Cardiometabolic Risk: Interactive Case Discussions
Session CM.CVS.1433
Location: N231
Moderator: Tiffany M. Powell-Wiley, M.D., M.P.H.
Panelists: Joniqua Ceasar, Tushar Acharya
3:45 p.m. Deep Phenotyping of Patients with Pulmonary Hypertension
Session VA.CVS.1608
Location: S106a
Moderator: Lei Xiao, M.D., Ph.D.
3:45 p.m. The Intersection of Aging, Sex, Race and Ethnicity: The Burden of Cardiovascular Disease in the Elderly
Session WS.CVS.1504
Location: N140
Panelist: George Mensah, M.D.
NHLBI-Funded Research
10:30 a.m. The Longitudinal Changes in Left Atrial Function is Associated With the Longitudinal Changes in N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
Session EP.APS.17: Su1044
Location: Zone 1, Science and Technology Hall
Presenter: Vinithra Varadarajan, Johns Hopkins Bloomberg School of Public Health
10:30 a.m. Non-Invasive Prediction of Pulmonary Hypertension Using Computerized Tomography
Session PH.APS.03: Su4219
Location: Zone 4, Science and Technology Hall
Presenter: Reshma Golamari, Mercy Catholic Medical Center
11:45 a.m. A Novel Risk Prediction Model of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA)
Session EP.AOS.02: 222
Location: N229
Presenter: Joshua David Bundy, M.P.H., Ph.D., Northwestern University Feinberg School of Medicine
2:00 p.m. Cardiovascular Risk Strata Among Persons' With Diabetes Mellitus: Post Hoc Analysis of the ACCORD Trial
Session EP.APS.24: Su1115
Location: Zone 1, Science and Technology Hall
Presenter: Brian Laughey, M.D., Wake Forest University School of Medicine=
2:00 p.m. Lifetime History of Smoking, Cessation and the Risk of Cardiovascular Disease: Prospective Results From the Framingham Heart Study
Session EP.APS.24: Su1116
Location: Zone 1, Science and Technology Hall
Presenter: Meredith S. Duncan, Vanderbilt University Medical Center
2:00 p.m. Physical Activity, Chronic Myocardial Injury and Risk of Heart Failure in African Americans: The Jackson Heart Study
Session EP.APS.24: Su1118
Location: Zone 1, Science and Technology Hall
Presenter: Shawn Simek, M.D., University of Texas Southwestern Medical Center
2:00 p.m. Physical Inactivity, Mortality and Incident Coronary Heart Disease in Blacks: The Jackson Heart Study
Session EP.APS.24: Su1122
Location: Zone 1, Science and Technology Hall
Presenter: Daisuke Kamimura, M.D., Ph.D., University of Mississippi Medical Center
2:00 p.m. Predictors of All Cause Mortality and Their Gender Differences in a Hispanic Population From Barranquilla-Colombia Using Machine Learning With Random Survival Forests
Session EP.APS.30: Su1179
Location: Zone 1, Science and Technology Hall
Presenter: Carlos A. Cure-Cure, M.D., BIOMELAB
2:00 p.m. Using Machine Learning Methods to Identify Predictors of Incident Myocardial Infarction in the Women’s Health Initiative Cohort
Session WS.APS.06: Su1361
Location: Zone 1, Science and Technology Hall
Presenter: Robert Avram, M.D., University of California San Francisco
2:00 p.m. Role of Caregiver Participation in Outcomes for Patients With Advanced Ambulatory Heart Failure: An Analysis of the REVIVAL Registry
Session HF.APS.33: Su2129
Location: Zone 2, Science and Technology Hall
Presenter: Nisha Gilotra, M.D., Johns Hopkins University School of Medicine
2:00 p.m. Predictive Value of Cardiopulmonary Exercise Testing Parameters for 1-Year Adverse Outcomes in Ambulatory Advanced Heart Failure
Session HF.APS.33: Su2132
Location: Zone 2, Science and Technology Hall
Presenter: Anuradha Lala-Trindade, M.D., Mount Sinai Health System
2:00 p.m. Does HRQOL Decline in Ambulatory Advanced Heart Failure Patients and Their Caregivers Over Time?
Session NR.APS.04: Su2323
Location: Zone 2, Science and Technology Hall
Presenter: Kathleen L. Grady, Ph.D., Northwestern University Feinberg School of Medicine
2:45 p.m. Increased Burden of Rare Germline Variants Associated With Increased Risk for Cancer and Bone Marrow Failure Among Patients With Congenital Heart Disease
Session CH.AOS.0: 187
Location: S101a
Presenter: Sarah U. Morton, M.D., Ph.D., Boston Children’s Hospital
4:45 p.m. Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality: The Lifetime Risk Pooling Project
Session LF.AOS.02: 288
Location: N230b
Presenter: Victor Wenze Zhong, Ph.D., Northwestern University Feinberg School of Medicine
Monday, November 12, 2018
NHLBI Research
9:00 a.m. George Lyman Duff Memorial Lecture
Session AT.AOS.03
Location: S105abc
Presenter: Alan T. Remaley, M.D., Ph.D.
1:00 p.m. Interrogating the Proteome to Elucidate Putatively Causal Biomarkers of Emphysema: The Framingham Heart Study
Session GE.APS.07: Mo1324
Location: Zone 1, Science and Technology
Panelist: Joshua Keefe
NHLBI Cardiovascular Seminars
7:15 a.m. Shedding Light on the Dark Genome: Noncoding RNAS in Cardiovascular Homeostasis and Disease
Session AT.CVS.2047
Location: S105abc
Moderator: Michelle Olive, Ph.D.
8:30 a.m. Bethesda +40: Bethesda Conference 1978
Session BC.CVS.100
Location: N227
Moderator: David Goff, M.D., Ph.D.
8:55 a.m. Bethesda +40: Subsequent Declines in CVD Mortality 1978-2010
Session BC.CVS.101
Location: N227
Moderator: David Goff, M.D., Ph.D.
Panelists: George Mensah, M.D., Gina Wei, M.D., M.P.H.
9:35 a.m. Bethesda +40: Current Stagnation in CV Mortality and Risk Factor Trends
Session BC.CVS.102
Location: N227
Moderator: David Goff, M.D., Ph.D.
10:35 a.m. Bethesda +40: The Future of the CVD Epidemic - Prevention and Research Opportunities, Untapped Potential, and Critical Questions to Address
Session BC.CVS.103
Location: N227
Moderator: David Goff, M.D., Ph.D.
Panelists: George Mensah, M.D., Gina Wei, M.D., M.P.H.
10:45 a.m. Epigenetics of Cardiac Resilience to Stress
Session CE.CVS.1308
Location: S101a
Moderator: Olga Tjurmina, Ph.D.
10:45 a.m. Mitochondria in Cardiovascular Health and Disease II
Session MP.CVS.1348
Location: S102d
Panelist: Elizabeth Murphy, Ph.D.
NHLBI-Funded Research
10:30 a.m. Novel Predictors of Incident Coronary Heart Disease in African Americans: A Metabolomic Investigation of the Jackson Heart Study
Session GE.APS.04: Mo3109
Location: Zone 3, Science and Technology Hall
Presenter: Daniel E. Cruz, M.D., Beth Israel Deaconess Medical Center
10:30 a.m. Proteomics Identifies Inflammatory, Lipid, and Cell Proliferative Pathways in Diastolic Dysfunction in HIV: A CHART Substudy
Session GE.APS.04: Mo3110
Location: Zone 3, Science and Technology Hall
Presenter: Svati H. Shah, M.D., M.H.S., Duke University School of Medicine
10:55 a.m. Frailty Phenotype is Associated with 1-Year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry
Session HF.RFO5: 516
Location: Zone 2, Science and Technology Hall
Presenter: Anuradha Lala-Trindade, M.D., Mount Sinai Health System
11:30 a.m. Development of Protease Proprotein Convertase Subtilisin-Like Kexin Type 9 Antagonists
Session AT.AOS.04: 121
Location: S105abc
Presenter: Nabil Elshourbagy, Ph.D., Shifa Biomedical Group
1:00 p.m. Novel Associations of Metabolites With Incident Heart Failure: Insights from the Jackson Heart Study
Session GE.APS.06: Mo1315
Location: Zone 1, Science and Technology Hall
Presenter: Usman Tahir, M.D., Beth Israel Deaconess Medical Center
1:00 p.m. International Survey of Patients Undergoing Percutaneous Coronary Intervention and Their Attitudes Towards Pharmacogenetic Testing
Session GE.APS.09: Mo1339
Location: Zone 1, Science and Technology Hall
Presenter: Naveen L. Pereira, M.D., Mayo Clinic